Justus Adamson1, Qiuwen Wu. 1. Department of Radiation Oncology, William Beaumont Hospital, Royal Oak, MI, USA.
Abstract
PURPOSE: To describe prostate intrafraction motion using kilovoltage fluoroscopy at treatment delivery for a hypofractionated radiotherapy protocol. METHODS AND MATERIALS: Kilovoltage images were acquired during treatment delivery, as well as pre- and posttreatment cone-beam computed tomography (CBCT) for each fraction of 30 patients, totaling 571 fractions for analysis. We calculated population statistics, evaluated correlation between interfraction and intrafraction motion, evaluated effect of treatment duration, classified whether motion resolved by posttreatment CBCT, and compared motion magnitude on a per-patient basis. RESULTS: The elapsed time between pre- and post-CBCTs was (18.6 ± 4.5) min. The population mean of motion measured by kilovoltage fluoroscopy was (-0.1, 0.5, -0.6) mm, the systematic was (0.5, 1.3, 1.2) mm, and random was (0.9, 1.9, 2.0) mm in the right-left, anterior-posterior, and superior-inferior axes, respectively. The probability of motion increased with treatment duration, with the mean increasing to (0.0, 1.0, -0.9) mm and the systematic to (0.6, 1.7, 1.5) mm when measured using posttreatment CBCT. For any motion ≥2 mm, approximately 75% did not resolve by posttreatment CBCT. Motion magnitude varied considerably among patients, with the probability of a 5-mm displacement ranging from 0.0% to 58.8%. CONCLUSIONS: Time dependency of intrafraction motion should be considered to avoid bias in margin assessment, with posttreatment CBCT slightly exaggerating the true motion. The patient-specific nature of the intrafraction motion suggests that a patient-specific management approach may be beneficial.
PURPOSE: To describe prostate intrafraction motion using kilovoltage fluoroscopy at treatment delivery for a hypofractionated radiotherapy protocol. METHODS AND MATERIALS: Kilovoltage images were acquired during treatment delivery, as well as pre- and posttreatment cone-beam computed tomography (CBCT) for each fraction of 30 patients, totaling 571 fractions for analysis. We calculated population statistics, evaluated correlation between interfraction and intrafraction motion, evaluated effect of treatment duration, classified whether motion resolved by posttreatment CBCT, and compared motion magnitude on a per-patient basis. RESULTS: The elapsed time between pre- and post-CBCTs was (18.6 ± 4.5) min. The population mean of motion measured by kilovoltage fluoroscopy was (-0.1, 0.5, -0.6) mm, the systematic was (0.5, 1.3, 1.2) mm, and random was (0.9, 1.9, 2.0) mm in the right-left, anterior-posterior, and superior-inferior axes, respectively. The probability of motion increased with treatment duration, with the mean increasing to (0.0, 1.0, -0.9) mm and the systematic to (0.6, 1.7, 1.5) mm when measured using posttreatment CBCT. For any motion ≥2 mm, approximately 75% did not resolve by posttreatment CBCT. Motion magnitude varied considerably among patients, with the probability of a 5-mm displacement ranging from 0.0% to 58.8%. CONCLUSIONS: Time dependency of intrafraction motion should be considered to avoid bias in margin assessment, with posttreatment CBCT slightly exaggerating the true motion. The patient-specific nature of the intrafraction motion suggests that a patient-specific management approach may be beneficial.
Authors: A R Padhani; V S Khoo; J Suckling; J E Husband; M O Leach; D P Dearnaley Journal: Int J Radiat Oncol Biol Phys Date: 1999-06-01 Impact factor: 7.038
Authors: Uulke A van der Heide; Alexis N T J Kotte; Homan Dehnad; Pieter Hofman; Jan J W Lagenijk; Marco van Vulpen Journal: Radiother Oncol Date: 2006-12-04 Impact factor: 6.280
Authors: Michel J Ghilezan; David A Jaffray; Jeffrey H Siewerdsen; Marcel Van Herk; Anil Shetty; Michael B Sharpe; Syed Zafar Jafri; Frank A Vicini; Richard C Matter; Donald S Brabbins; Alvaro A Martinez Journal: Int J Radiat Oncol Biol Phys Date: 2005-06-01 Impact factor: 7.038
Authors: Ruijiang Li; Bin Han; Bowen Meng; Peter G Maxim; Lei Xing; Albert C Koong; Maximilian Diehn; Billy W Loo Journal: Int J Radiat Oncol Biol Phys Date: 2013-10-08 Impact factor: 7.038
Authors: Maria Antico; Peter Prinsen; Francesco Cellini; Alice Fracassi; Alfonso A Isola; David Cobben; Davide Fontanarosa Journal: PLoS One Date: 2019-02-28 Impact factor: 3.240
Authors: Ruijiang Li; Edward Mok; Daniel T Chang; Megan Daly; Billy W Loo; Maximilian Diehn; Quynh-Thu Le; Albert Koong; Lei Xing Journal: Int J Radiat Oncol Biol Phys Date: 2012-05-02 Impact factor: 7.038
Authors: Juan Diego Azcona; Ruijiang Li; Edward Mok; Steven Hancock; Lei Xing Journal: Int J Radiat Oncol Biol Phys Date: 2013-04-19 Impact factor: 7.038
Authors: Valeria Meier; Chris Staudinger; Stephan Radonic; Jürgen Besserer; Uwe Schneider; Linda Walsh; Carla Rohrer Bley Journal: Vet Comp Oncol Date: 2021-01-06 Impact factor: 2.613
Authors: Prabhjot Juneja; Andrew Kneebone; Jeremy T Booth; David I Thwaites; Ramandeep Kaur; Emma Colvill; Jin A Ng; Paul J Keall; Thomas Eade Journal: Radiat Oncol Date: 2015-10-24 Impact factor: 3.481